eamdacademy.org-UtTc-1792716774-z846227873 1792716774 Eurasian Academy of Medicine and Dentistry info@eamdacademy.org Eurasian Academy of Medicine and Dentistry Journal of Applied Pharmaceutical Technologies and Systems J Appl Pharm Technol Syst 3149-9589 2024 3 2 Claire Martin Julien Robert Sophie Bernard Antoine Girard 2024 10.68159/z846227873 https://eamdacademy.org/pub/journal/3/article/z846227873 Yang J, Cao Z. Glucose-responsive insulin release: analysis of mechanisms, formulations, and evaluation criteria. J Control Release. 2017;263:231-9. Das SS, Bharadwaj P, Bilal M, Barani M, Rahdar A, Taboada P, et al. Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis. Polymers (Basel). 2020;12(6):1397. Zhang J, Lin Y, Lin Z, Wei Q, Qian J, Ruan R, et al. Stimuli-responsive nanoparticles for controlled drug delivery in synergistic cancer immunotherapy. Adv Sci (Weinh). 2022;9(5):2103444. Wang Z, Wang J, Kahkoska AR, Buse JB, Gu Z. Developing insulin delivery devices with glucose responsiveness. Trends Pharmacol Sci. 2021;42(1):31-44. Howsmon DP, Cameron F, Baysal N, Ly TT, Forlenza GP, Maahs DM, et al. Continuous glucose monitoring enables the detection of losses in infusion set actuation (LISAs). Sensors (Basel). 2017;17(1):161. Taha MS, Padmakumar S, Singh A, Amiji MM. Critical quality attributes in the development of therapeutic nanomedicines toward clinical translation. Drug Deliv Transl Res. 2020;10(3):766-90. Miller MK, Chapa-Villarreal FA, Oldenkamp HF, Elder MG, Venkataraman AK, Peppas NA. Stimuli-responsive self-assembled polymer nanoparticles for the oral delivery of antibodies. J Control Release. 2023;361:246-59. Aiello EM, Jaloli M, Cescon M. Model predictive control (MPC) of an artificial pancreas with data-driven learning of multi-step-ahead blood glucose predictors. Control Eng Pract. 2024;144:105810. Zhang C, Hong S, Liu MD, Yu WY, Zhang MK, Zhang L, et al. pH-sensitive MOF integrated with glucose oxidase for glucose-responsive insulin delivery. J Control Release. 2020;320:159-67. Beneyto A, Bequette BW, Vehí J. Fault tolerant strategies for automated insulin delivery considering the human component: current and future perspectives. J Diabetes Sci Technol. 2021;15(6):1224-31. Wang J, Wang Z, Yu J, Kahkoska AR, Buse JB, Gu Z. Glucose-responsive insulin and delivery systems: innovation and translation. Adv Mater. 2020;32(13):1902004. Yu J, Wang J, Zhang Y, Chen G, Mao W, Ye Y, et al. Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs. Nat Biomed Eng. 2020;4(5):499-506. Howsmon DP, Baysal N, Buckingham BA, Forlenza GP, Ly TT, Maahs DM, et al. Real-time detection of infusion site failures in a closed-loop artificial pancreas. J Diabetes Sci Technol. 2018;12(3):599-607. Liu HC, Zhang LJ, Ping YJ, Wang L. Failure mode and effects analysis for proactive healthcare risk evaluation: a systematic literature review. J Eval Clin Pract. 2020;26(4):1320-37. Bonaccorso A, Russo G, Pappalardo F, Carbone C, Puglisi G, Pignatello R, et al. Quality by design tools reducing the gap from bench to bedside for nanomedicine. Eur J Pharm Biopharm. 2021;169:144-55. Meneghetti L, Susto GA, Del Favero S. Detection of insulin pump malfunctioning to improve safety in artificial pancreas using unsupervised algorithms. J Diabetes Sci Technol. 2019;13(6):1065-76. Meneghetti L, Terzi M, Del Favero S, Susto GA, Cobelli C. Data-driven anomaly recognition for unsupervised model-free fault detection in artificial pancreas. IEEE Trans Control Syst Technol. 2020;28(1):33-47. Ozaslan B, Levy CJ, Kudva YC, Pinsker JE, O'Malley G, Kaur RJ, et al. Feasibility of closed-loop insulin delivery with a pregnancy-specific zone model predictive control algorithm. Diabetes Technol Ther. 2022;24(7):471-80. Alshaer W, Nsairat H, Lafi Z, Hourani OM, Al-Kadash A, Esawi E, et al. Quality by design approach in liposomal formulations: robust product development. Molecules. 2022;28(1):10. DeGrazio F, Paskiet D. Injectable combination product development: facilitating risk-based assessments for efficiency and patient centric outcomes. J Pharm Sci. 2020;109(7):2101-15. Kumoluyi R, Khanolkar A. Risk management in drug-device combination product development. Ther Innov Regul Sci. 2022;56(5):685-8. Shen D, Yu H, Wang L, Khan A, Haq F, Chen X, et al. Recent progress in design and preparation of glucose-responsive insulin delivery systems. J Control Release. 2020;321:236-58. Kühler TC, Schoenmakers M, Shergold O, Affolter S, Bolislis WR, Foster R, et al. Development and regulation of connected combined products: reflections from the MedTech & Pharma Platform Association. Clin Ther. 2022;44(5):768-82. Thakur NS, Rus I, Sparks E, Agrahari V. Dual stimuli-responsive and sustained drug delivery NanoSensoGel formulation for prevention of cisplatin-induced ototoxicity. J Control Release. 2024;368:66-83. Long J, Liang X, Ao Z, Tang X, Li C, Yan K, et al. Stimulus-responsive drug delivery nanoplatforms for inflammatory bowel disease therapy. Acta Biomater. 2024;188:27-47. He Y, Chen N, Zang M, Zhang J, Zhang Y, Lu H, et al. Glucose-responsive insulin microneedle patches for long-acting delivery and release visualization. J Control Release. 2024;368:430-43. Anjalee JA, Rutter V, Samaranayake NR. Application of Failure Mode and Effect Analysis (FMEA) to improve medication safety: a systematic review. Postgrad Med J. 2021;97(1145):168-74. Shen D, Yu H, Wang L, Feng J, Zhang Q, Pan J, et al. Glucose-responsive nanoparticles designed via a molecular-docking-driven method for insulin delivery. J Control Release. 2022;352:527-39.